
Sensible Biotechnologies
Novel mRNA manufacturing paradigm to establish critical biomanufacturing infrastructure for global biosecurity.
Employees
Enterprise value
$17—25m
Authorizing premium user...
Novel mRNA manufacturing paradigm to establish critical biomanufacturing infrastructure for global biosecurity.